Aduro Clean Technologies (ACT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 Jan, 2026Executive summary
Achieved key operational milestones, including commissioning of the Next Generation Process (NGP) Pilot Plant and progress on the Demonstration Plant program, with global site selection underway.
Strengthened capital position post-quarter with a US$20 million public offering to support demonstration plant, R&D, and corporate activities.
Initiated engineering trials and collaborations to advance technology scale-up and market engagement.
Financial highlights
Q2 2026 revenue was $122,706, up 222% year-over-year; six-month revenue was $167,206, up 80%.
Loss from operations for Q2 2026 was $6,461,987, more than double the prior year; six-month loss was $12,787,005.
Adjusted EBITDA for Q2 2026 was $(3,299,026), compared to $(1,887,750) in Q2 2025; six-month adjusted EBITDA was $(5,553,410).
Cash position at November 30, 2025, was $13.04 million, up from $6.96 million at Q4 2025.
Property, plant, and equipment carrying cost increased to $8.9 million, driven by NGP Pilot Plant construction.
Outlook and guidance
Proceeds from the public offering will primarily fund the Demonstration Plant program, R&D, and general corporate purposes.
Final site selection for the Demonstration Plant anticipated by end of January 2026.
Ongoing engineering trials and collaborations to inform equipment design and integration for demonstration-scale operations.
Latest events from Aduro Clean Technologies
- Innovative recycling tech enables low-cost, scalable plastic waste conversion, with strong industry traction.ACT
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Innovative recycling platform targets landfill plastics with scalable, flexible business models.ACT
H.C. Wainwright 27th Annual Global Investment Conference31 Dec 2025 - Pilot plant commissioning advanced, cash reserves grew, but revenue fell and losses widened.ACT
Q1 202630 Dec 2025 - Pilot plant progress, industry collaborations, and strong financing offset lower revenue and higher losses.ACT
Q4 202522 Sep 2025 - Revenue surged 208% year-over-year as technology and global partnerships advanced.ACT
Q4 20241 Jul 2025 - Advanced R&D, new patent, and strong cash position support technology scale-up and growth.ACT
Q1 20251 Jul 2025 - Nasdaq uplisting, new funding, and pilot plant advances drive commercialization amid revenue decline.ACT
Q2 20251 Jul 2025 - Q3 2025 saw lower revenue and higher losses, but key milestones and strong cash support growth.ACT
Q3 20251 Jul 2025